A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

NCT07269587 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

275

Enrollment

OTHER

Sponsor class

Conditions

ALL (Acute B-Lymphoblastic Leukemia)
CAR-T Cell Therapy

Interventions

DRUG: CNCT-19

Sponsor

Ruijin Hospital